Back to results
US 2010/0075963 A1Published application
Pharmaceutically Active Benzensulphonyl-Indols
AssigneeNovartis AG
InventorsPhilipp Lehr, Anthony Winiski
Life of this patent
Estimating the term…
Abstract
1-Benzenesulfonyl-1H-indoles, processes for their production and their use as pharmaceuticals, e.g. in the treatment of disorders which are mediated by CCR9, such as e.g. inflammatory bowel disease.
Claims11
A method of treating a disorder mediated by CCR9 activity which comprises the step of administering to a patient having a disorder mediated by CCR9 activity a compound of formula
- wherein
- R1 is (C1-12)alkyl, (C1-12)alkoxy, (C3-12)cycloalkyl, optionally fused with heterocyclyl, (C5-12)cycloalkenyl, optionally fused with heterocyclyl, (C6-18)aryl, optionally fused with heterocyclyl, heterocyclyl, halogen, halo(C1-4)alkyl, (C1-4)alkoxy, halo(C1-4alkoxy, (C1-4)alkylthio,
- wherein heterocyclyl is aliphatic or aromatic heterocyclyl comprising 3 to 12 ring members and 1 to 4 heteroatoms selected from N, O, S, optionally anellated with another ring system,
- wherein cycloalkyl, cycloalkenyl, aryl or heterocyclyl are unsubstituted or substituted, by one or more halogen, halo(C1-4)alkyl, halo(C1-4alkoxy, (C1-4)alkyl, (C1-4)alkoxy or
- (C1-4)alkylthio,
- R2 and R3 are different from each other and independently are hydrogen, hydroxycarbonyl, alkoxycarbonyl, e.g. (C1-4)alkoxycarbonyl, cyano,
- aminocarbonyl, wherein amino is NH2, one- or twofold substituted amino or a cyclic amine, halogen, halo(C1-4)alkyl, such as CF3, (C1-4)alkyl, (C1-4)alkoxy, (C1-4)alkylthio in free form or in the form of a salt.
4 more elements
A compound of formula
- wherein
- R1 is branched (C4-12)alkyl, (C1-12)alkoxy, (C3-12)cycloalkyl, optionally fused with heterocyclyl, (C5-12)cycloalkenyl, optionally fused with heterocyclyl, (C6-18)aryl, optionally fused with heterocyclyl, heterocyclyl, chloro or fluoro, halo(C1-4)alkyl, (C1-4)alkoxy, halo(C1-4)alkoxy, (C1-4)alkylthio,
- wherein heterocyclyl is aliphatic or aromatic heterocyclyl comprising 3 to 12 ring members and 1 to 4 heteroatoms selected from N, O, S, optionally anellated with another ring system,
- wherein cycloalkyl, cycloalkenyl, aryl or heterocyclyl are unsubstituted or substituted by one or more halogen, halo(C1-4)alkyl, halo(C1-4)alkoxy, (C1-4)alkyl, (C1-4)alkoxy or
- (C1-4)alkylthio,
- R2 and R3 are different from each other and independently are hydrogen, hydroxycarbonyl, alkoxycarbonyl, e.g. (C1-4)alkoxycarbonyl, cyano,
- aminocarbonyl, wherein amino is NH2, one- or twofold substituted amino or a cyclic amine, with the proviso that if R2 is 4-methyl-piperazin-1-yl-carbonyl, then R2 is in position 3 of the ring system,
- chloro, halo(C1-4)alkyl, such as CF3, (C1-4)alkyl, (C1-4)alkoxy, (C1-4)alkylthio
- with the PROVISO that
- a compound of formula
- and a compound of formula
- are EXCLUDED.
9 more elements
A compound from the group selected from consisting of
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-2-carboxylic acid,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-6-carboxylic acid,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-7-carboxylic acid methyl ester,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-3-carboxylic acid,
- 5-Chloro-1-(4-morpholin-4-yl)-benzenesulfonyl)-1H-indole-3-carboxylic acid,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carboxylic acid,
- 5-Chloro-1-(4-oxazol-5-yl)-benzenesulfonyl)-1H-indole-3-carboxylic acid,
- 5-Chloro-1-(4-trifluoromethyl-benzenesulfonyl)-1H-indole-3-carboxylic acid,
- 5-Chloro-1-(4-chloro-benzenesulfonyl)-1H-indole-3-carboxylic acid,
- 5-Chloro-1-(4-morpholin-4-yl-benzenesulfonyl)-1H-indole-2-carboxylic acid,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-2-carboxylic acid,
- 1-(4-Morpholin-4-yl-benzenesulfonyl)-1H-indole-6-carboxylic acid methyl ester,
- 1-(4-Morpholin-4-yl-benzenesulfonyl)-1H-indole-6-carboxylic acid,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-2-carboxylic acid amide,
- [1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indol-3-yl]-morpholin-4-yl-methanone,
- 2-{[1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carbonyl]amino}-2-methyl-propionic acid,
- [1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indol-3-yl]-(4-methyl-piperazin-1-yl)-methanone,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carboxylic acid methylamide,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carboxylic acid dimethylamide,
- [1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-yl]-piperidin-1-yl-methanone,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carboxylic acid amide,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-3-carboxylic acid isopropylamide,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-6-carbonitrile,
- 1-(4-tert.Butyl-benzenesulfonyl)-5-chloro-1H-indole-2-carbonitrile,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-3-carbonitrile,
- 1-(4-tert.Butyl-benzenesulfonyl)-1H-indole-6-carboxylic acid amide and
- 4-tert.Butyl-N-[1-(4-tert-butyl-benzenesulfonyl)-1H-indole-6-carbonyl]-benzenesulfon-amide,
24 more elements
(canceled)
Dependencies are inferred from the claim text.